Houlihan Lokey, Inc.
NYSE:HLIFinancial - Capital Markets
-$1.78 today
- Market cap
- $9.66B
- Beta
- 0.95
- P/E (TTM)
- 22.0
- EPS (TTM)
- $6.42
- Dividend yield
- 1.77%
Volume 0.57M
Average 0.67M
HLI EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Houlihan Lokey, Inc.NYSE: HLI
EBITDA · Q2 FY2027 · quarter ended Sep 2026
EBITDA declines year over year
Q2 FY2027 EBITDA of $168M fell 6.3% year over year, ahead of the -11.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 95.3% from the prior quarter. Over 3 fiscal years it compounded at +11.6% a year.
Context
- EBITDA amounted to 23.1% of revenue in FY2026, down 1.9 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 8 analysts of $711.5M (+17.6%) for the fiscal year ending Mar 2027, a step up from the +1.2% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $168M+95.3% QoQ
- Last fiscal yearMar 2026
- $604.9M+1.2% YoY
- LTMSep 2026
- $583.16M-11.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -6.3% | +2.5% | +8.8 pp |
| 1 year | +1.2% | +17.6% | +16.4 pp |
| 3-year CAGR | +11.6% | +13.5% | +1.9 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2026
- 604.9M USD
- Year-over-year change
- +1.2%
- 4-year CAGR
- -2.2%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 604.9M | +1.2% |
| FY2025 | 2025-03-31 | 597.59M | +39.7% |
| FY2024 | 2024-03-31 | 427.63M | -1.7% |
| FY2023 | 2023-03-31 | 435.03M | -34.2% |
| FY2022 | 2022-03-31 | 661.4M | — |
EBITDA vs competitors
How HLI compares with its peers on the latest reported figures
- HLI's LTM Sep 2026 EBITDA of $583.16M is the 7th highest of the 11 companies compared; the peer median is $1.51B.
- Its year-over-year change of -11.3% is the 9th highest of 11, against a peer median of +36.6%.
- EBITDA amounts to 22.8% of revenue for HLI, versus a peer median of 23.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $33.01B | +41.0% | +14.7% | 26.7% | |
| LTM Sep 2026 | $29.65B | +12.9% | +13.7% | 22.9% | |
| LTM Jun 2026 | $21.15B | +97.9% | +4.2% | 27.8% | |
| LTM Aug 2026 | $2.35B | -37.6% | -23.7% | 18.8% | |
| LTM Sep 2026 | $1.96B | +115.2% | +0.4% | 29.3% | |
| LTM Jun 2026 | $1.05B | +73.2% | +3.2% | 22.2% | |
| LTM Sep 2026 | $583.16M | -11.3% | +11.6% | 22.8% | |
| LTM Jun 2026 | $515.58M | +112.6% | +35.7% | 24.5% | |
| LTM Jun 2026 | $443.13M | +32.1% | +13.8% | 23.5% | |
| LTM Sep 2026 | $358.38M | -23.9% | -13.8% | 10.6% | |
| LTM Sep 2026 | $349.59M | +21.1% | +14.8% | 21.3% | |
| Peer median (excluding HLI) | $1.51B | +36.6% | +9.0% | 23.2% | |
Competitors are the stored peer set for HLI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 2.27B | 1.81B | 1.91B | 2.39B | 2.62B |
| Cost of Revenue | 1.41B | 1.11B | 1.18B | 1.47B | 42.63M |
| Gross Profit | 861.32M | 696.64M | 737.05M | 919.93M | 2.57B |
| Gross Margin | 37.9% | 38.5% | 38.5% | 38.5% | 98.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 127.81M | 142.9M | 185.32M | 188.48M | 0 |
| Operating Expenses | 248.46M | 354.9M | 374.19M | 418.38M | 1.96B |
| Depreciation & Amortization | 48.54M | 58.22M | 28.54M | 41.27M | 42.63M |
| EBITDA | 661.4M | 435.03M | 427.63M | 597.59M | 604.9M |
| EBITDA Margin | 29.1% | 24.0% | 22.3% | 25.0% | 23.1% |
| Operating Income | 612.86M | 341.74M | 362.86M | 501.54M | 618.54M |
| Operating Margin | 27.0% | 18.9% | 19.0% | 21.0% | 23.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (8.93M) | (17.74M) | 27.68M | 29.79M | (56.27M) |
| Income Before Tax | 603.94M | 324M | 390.54M | 531.34M | 562.27M |
| Pre-Tax Margin | 26.6% | 17.9% | 20.4% | 22.2% | 21.5% |
| Income Tax Expense | 165.61M | 69.78M | 110.24M | 131.62M | 138.09M |
| Net Income | 437.75M | 254.22M | 280.3M | 399.71M | 425.7M |
| Net Margin | 19.3% | 14.0% | 14.6% | 16.7% | 16.3% |
| EPS (Basic) | 6.74 | 4.01 | 4.36 | 6.08 | 6.40 |
| EPS (Diluted) | 6.41 | 3.76 | 4.11 | 5.82 | 6.22 |
| Weighted Avg Shares | 64.97M | 63.36M | 64.34M | 65.72M | 66.55M |
| Weighted Avg Shares (Diluted) | 68.26M | 67.59M | 68.16M | 68.66M | 68.43M |
Houlihan Lokey, Inc.
NYSE:HLI
Intrinsic Alpha fair value
Locked
Current Price
$139.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.